4//SEC Filing
Brennan Kevin M. 4
Accession 0001415889-24-024463
CIK 0001840233other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:15 PM ET
Size
5.5 KB
Accession
0001415889-24-024463
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2024-10-01+26,000→ 26,000 totalExercise: $0.75Exp: 2034-09-30→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 1, 2024 and will vest as to 100% of the shares underlying the option on September 30, 2025, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through the vesting date.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001971303
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:15 PM ET
- Size
- 5.5 KB